Page Arthur B Merck & Co., Inc. Transaction History

Page Arthur B

$96 Million
Q1 2024

A detailed history of Page Arthur B transactions in Merck & Co., Inc. stock. As of the latest transaction made, Page Arthur B holds 2,768 shares of MRK stock, worth $275,969. This represents 0.38% of its overall portfolio holdings.

Number of Shares

2,768

Previous 2,768 -0.0%

Holding current value

$275,969

Previous $301,000 21.26%

% of portfolio

0.38%

Previous 0.32%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$100.18 - $109.02 $5,009 - $5,451	-50 Reduced 1.77%	2,768 $301,000
Q3 2023 Nov 14, 2023	SELL	$102.95 - $114.33 $5,147 - $5,716	-50 Reduced 1.74%	2,818 $290,000
Q2 2023 Aug 14, 2023	SELL	$108.61 - $118.38 $81,457 - $88,785	-750 Reduced 20.73%	2,868 $330,000
Q3 2022 Nov 08, 2022	SELL	$84.53 - $94.96 $5,748 - $6,457	-68 Reduced 1.84%	3,618 $312,000
Q1 2022 May 16, 2022	SELL	$73.51 - $82.4 $14,702 - $16,480	-200 Reduced 5.15%	3,686 $302,000
Q2 2021 Aug 09, 2021	SELL	$70.31 - $77.77 $9,140 - $10,110	-130 Reduced 3.24%	3,886 $303,000
Q1 2021 May 17, 2021	SELL	$68.86 - $81.11 $68 - $81	-1 Reduced 0.02%	4,016 $309,000
Q4 2020 Feb 16, 2021	BUY	$71.77 - $79.65 $288,300 - $319,954	4,017 New	4,017 $329,000
Q2 2019 Jul 24, 2019	SELL	$69.84 - $81.59 $172,784 - $201,853	-2,474 Closed	0 $0
Q1 2019 Apr 29, 2019	BUY	$69.58 - $79.36 $172,140 - $196,336	2,474 New	2,474 $206,000
Q4 2017 Feb 02, 2018	SELL	$51.62 - $61.64 $184,747 - $220,609	-3,579 Closed	0 $0
Q3 2017 Oct 26, 2017	BUY	$58.67 - $63.13 $209,979 - $225,942	3,579	3,579 $229,000

Others Institutions Holding MRK

# of Institutions

3,827

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $253B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Page Arthur B, based on Form 13F filings with the SEC.

News

Stay updated on Page Arthur B with notifications on news.

Account